Blog

Advancing Therapeutic Strategies for Medulloblastoma: Insights from Dr. Luiz Penalva and Dr. Andrew Beekman

Date
October 7, 2025
Dr. Luiz Penalva of UT Health Science Center and Dr. Andrew Beekman of the University of East Anglia presented groundbreaking research focused on ribosomal RNA (rRNA) modification and its role in the progression of medulloblastoma, one of the most aggressive pediatric brain tumors. Their collaborative work explores how targeting fundamental cellular mechanisms may open new therapeutic avenues. Ribosome Biogenesis and Medulloblastoma Dr. Penalva explained that cancer cells, including medullo